2 dark yellow tab each containing estradiol valerate 3 mg, 5 medium red tab each containing estradiol valerate 2 mg, dienogest 2 mg, 17 light yellow tab each containing estradiol valerate 2 mg, dienogest 3 mg, 2 dark red tab each containing estradiol valerate 1 mg, 2 white inactive tab
Indications/Uses
Prevention of pregnancy. Treatment of heavy menstrual bleeding in women w/o organic pathology who desire oral contraception.
View Qlaira overdosage for action to be taken in the event of an overdose.
Administration
May be taken with or without food.
Contraindications
Hypersensitivity. Thrombosis, pulmonary embolism, heart attack or stroke, angina pectoris, severe or multiple risk factors for blood clots, migraine, DM w/ damaged blood vessels, liver impairment, cancer or suspected cancer of the breast or genital organs, liver tumor, unexplained vag bleeding. Pregnancy.
Smoking; diabetes; jaundice; depression; overwt; HTN; heart valve or heart rhythm disorders; superficial phlebitis; varicose veins; history of leg thrombosis, pulmonary embolism, stroke; migraine; epilepsy; history of hypercholesterolaemia or hypertriglyceridaemia; history of breast cancer; liver or gallbladder disease; Crohn's disease or ulcerative colitis; SLE; hemolytic uremic syndrome; sickle cell disease; hearing impairment, porphyria, herpes gestationis, Sydenham's chorea. Pregnancy patches, chloasma; avoid direct exposure to sunlight or UV light. Hereditary angioedema. Cardiac or renal insufficiency. Discontinue when signs of blood clot or cerebral stroke occur. Lactation. Adolescent <18 yr.
Sign Out
